Cytotoxicity of T cells for cerebral endothelium in multiple sclerosis

We investigated the cytotoxic effect of peripheral blood T cells on cerebral endothelium in patients with MS. We examined in vitro the damage to 51Cr-labelled dissociated human brain endothelial cells produced by mitogen-stimulated T cell lines from patients with MS and controls. Endothelial targets...

Full description

Saved in:
Bibliographic Details
Published inJournal of the neurological sciences Vol. 117; no. 1; pp. 140 - 147
Main Authors Tsukada, Naoyuki, Matsuda, Masayuki, Miyagi, Koichi, Yanagisawa, Nobuo
Format Journal Article
LanguageEnglish
Published Shannon Elsevier B.V 01.07.1993
Elsevier Science
Subjects
Online AccessGet full text
ISSN0022-510X
1878-5883
DOI10.1016/0022-510X(93)90166-V

Cover

More Information
Summary:We investigated the cytotoxic effect of peripheral blood T cells on cerebral endothelium in patients with MS. We examined in vitro the damage to 51Cr-labelled dissociated human brain endothelial cells produced by mitogen-stimulated T cell lines from patients with MS and controls. Endothelial targets were lysed by T-lymphocytes from patients with acute relapsing MS during an exacerbation at every target-effector cell ratio tested compared with controls ( P < 0.001). The percentage of endothelial targets lysed was not significantly increased by incubation with T cells from patients with acute relapsing MS in remission and chronic progressive MS, compared with that of normal subjects. Relapsing MS patients during an exacerbation had significantly higher interleukin-1 (IL-1)-α concentrations in cultures of targets with effector cells than normal subjects ( P < 0.02). Experiments of major histocompatibility complex (MHC)-restricted cytotoxicity in MS demonstrated incomplete blocking of specific lysis by either anti-MHC class I or class II monoclonal antibody (mAb). These results indicate that cytotoxicity of T cells for cerebral endothelial cells may play a role in the initiation of immune response in acute relapsing MS during an exacerbation which appears to cause an increase in blood-brain barrier (BBB) permeability.
Bibliography:ObjectType-Article-2
SourceType-Scholarly Journals-1
ObjectType-Feature-1
content type line 23
ISSN:0022-510X
1878-5883
DOI:10.1016/0022-510X(93)90166-V